Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Daclatasvir Dihydrochloride CAS 1009119-65-6

Daclatasvir Dihydrochloride CAS 1009119-65-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1009119-65-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1009119-65-6(Free Base: 1009119-64-5)
Appearance ::
White To Yellow Crystalline Powder
Molecular Formula::
C40H52Cl2N8O6
Molecular Weight::
811.8
EINECS NO::
816-965-3
MDL NO::
MFCD25541736
CAS NO::
1009119-65-6(Free Base: 1009119-64-5)
Appearance ::
White To Yellow Crystalline Powder
Molecular Formula::
C40H52Cl2N8O6
Molecular Weight::
811.8
EINECS NO::
816-965-3
MDL NO::
MFCD25541736
Daclatasvir Dihydrochloride CAS 1009119-65-6

Product Description:

Product Name: Daclatasvir dihydrochloride CAS NO: 1009119-65-6

 

Synonyms:

BMS-790052 (dihydrochloride);

Methyl (1-((2S)-2-(5-(4'-(2-(1-((methoxycarbonyl)valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate hydrochloride;

Dimethyl N,N'-(biphenyl-4,4'-diylbis(1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)))dicarbamate dihydrochloride;

 

 

Chemical & Physical Properties:

Appearance : White to Yellow crystalline powder

Assay : ≥99.0%

Density: N/A

Melting point: >207℃

Boiling Point: N/A

Flash Point: N/A

Specific optical rotation: -155°~165°

Refractive Index: N/A

Vapor Pressure: 0.0mmHg at 25°C

PSA: 181.62000

LogP: 8.11060

Solubility: DMSO (Slightly), Methanol (Slightly), Water (Slightly).

Category: Standards; Pharmaceutical/API Drug Impurities/Metabolites;

 

 

Safety Information:

HS Code: 2933990090

 

Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.

 

Application:

Daclatasvir Dihydrochloride is an anti-hepatitis C drug.

BMS-790052 is a highly selective inhibitor of HCV NS5A , for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture.

 

Our factory manufacture’s Daclatasvir dihydrochloride CAS 1009119-65-6 , mature technology, stable output, quality assurance.

Inventory Status : In Stock.

 

We can provide BMS-790052 2HCl CAS 1009119-65-6 COA (certificate of analysis), DACLATASVIR 2HCl MOA (Method of Analysis), Dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate dihydrochloride ROS (Route of synthesis), methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate,dihydrochloride MSDS (Material Safety Data Sheet) and other support for you !

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.